text_1: BRCA 1 mutation carriers' risk of breast and ovarian cancer depends on where the mutation is located.
text_2: Among BRCA2 mutation carriers, 6180 women (52%) were diagnosed with breast cancer, 682 (6%) with ovarian cancer, 272 (2%) with breast and ovarian cancer, and 4766 (40%) without cancer.